Protection against liver injury by PGE1 or anti-TNF- is associated with a reduction of TNF-R1 expression in hepatocytes

Author： Lozano J. M.   Collado J. A.   Medina T.   Muntané J.  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.38, Iss.11, 2003-11, pp. : 1169-1175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complications of anti-TNF therapies

By Ding Tina   Deighton Chris  

Future Rheumatology, Vol. 2, Iss. 6, 2007-12 ,pp. : 587-597

Future Medicine

Access to resources Recommend Favorite

Tuberculosis after anti-TNF therapy

By Pamuk Ömer   Dönmez Salim  

Clinical Rheumatology, Vol. 28, Iss. 6, 2009-06 ,pp. : 747-747

Springer Publishing Company

Access to resources Recommend Favorite

Mucosal Healing with Anti-TNF Antibodies

By  

Digestion, Vol. 86, Iss. 1, 2012-10 ,pp. : 16-22

Karger

Access to resources Recommend Favorite

Effects of a PEGylated soluble TNF receptor type 1 (PEG sTNF-RI)on cytokine expression in adjuvant arthritis

By Bush K.A.   Walker J. S.   Frazier J.   Kirkham B. W.  

Scandinavian Journal of Rheumatology, Vol. 31, Iss. 4, 2002-08 ,pp. : 198-204

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of the anti-TNF biologic agents

By Weaver Arthur L.  

Modern Rheumatology, Vol. 14, Iss. 2, 2004-06 ,pp. : 101-112

Springer Publishing Company

Access to resources Recommend Favorite